HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lianqu Li Selected Research

Poly I-C

10/2018Formononetin attenuated allergic diseases through inhibition of epithelial-derived cytokines by regulating E-cadherin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lianqu Li Research Topics

Disease

3Inflammation (Inflammations)
01/2021 - 01/2018
1Asthma (Bronchial Asthma)
01/2021
1Atopic Dermatitis (Atopic Eczema)
11/2019
1Contact Dermatitis (Eczema, Contact)
10/2018
1Dermatitis
01/2018
1Hypersensitivity (Allergy)
01/2018
1Allergic Contact Dermatitis
01/2018

Drug/Important Bio-Agent (IBA)

1ErbB Receptors (EGF Receptor)IBA
01/2021
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021
1AllergensIBA
11/2019
1Fluorescein (Funduscein)FDA LinkGeneric
10/2018
1isothiocyanic acidIBA
10/2018
1InterleukinsIBA
10/2018
1LipopolysaccharidesIBA
10/2018
1Poly I-CIBA
10/2018
1Cadherins (E-Cadherin)IBA
10/2018
1Thymic Stromal LymphopoietinIBA
10/2018
1Anti-Allergic Agents (Antiallergic Agents)IBA
01/2018
1Huang QiIBA
01/2018
17,3'-dihydroxy-4'-methoxyisoflavoneIBA
01/2018
1CytokinesIBA
01/2018
1Fluorescein-5-isothiocyanate (FITC)IBA
01/2018

Therapy/Procedure

1Therapeutics
01/2018